Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study

Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients:... ABSTRACT Aims We sought to evaluate the safety and efficacy of the GABAergic agent tiagabine in reducing cocaine use among methadone‐treated patients. Design Ten‐week randomized double‐blind placebo‐controlled trial. Setting Opiate Treatment Research Program, Veteran's Affairs Connecticut Healthcare System in West Haven, Connecticut, USA. Participants The participants were 45 cocaine‐dependent methadone‐treated patients who were predominately Caucasian (75.6%), male (77.8%) and never married (53%) with an average age of 38 years (SD = 6.5). Interventions Comparison groups received tiagabine 12 mg/day (n = 15), tiagabine 24 mg/day (n = 15) or placebo (n = 15). Measures Baseline assessments included the Structured Clinical Interview for DSM‐IV, the Addiction Severity Index, a urine drug test, self‐reported use and opiate withdrawal scales. Urine drug tests were performed thrice weekly. Findings Treatment retention was over 80% for all treatment groups. The sample mean (± SE) of cocaine‐free urines for the first week after study entry and before tiagabine was started was 1.16 (0.19) urines/week. During weeks 9 and 10 cocaine‐free urines increased significantly from baseline by 33% with high‐dose tiagabine (24 mg/day), by 14% with low‐dose tiagabine (12 mg/day) and decreased by 10% with placebo (hierarchical linear model, Z= 2.03; P < 0.05). Self‐reported cocaine use also decreased significantly more with active medications than with placebo. Conclusions Tiagabine at 24 mg/day was well tolerated among these methadone‐treated patients with only one reporting headache. Tiagabine appears to be a promising GABAergic medication that moderately improves cocaine‐free urines. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Addiction Wiley

Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study

Loading next page...
 
/lp/wiley/tiagabine-increases-cocaine-free-urines-in-cocaine-dependent-methadone-jV8Z0AeOcD
Publisher
Wiley
Copyright
Copyright © 2003 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0965-2140
eISSN
1360-0443
D.O.I.
10.1046/j.1360-0443.2003.00544.x
Publisher site
See Article on Publisher Site

Abstract

ABSTRACT Aims We sought to evaluate the safety and efficacy of the GABAergic agent tiagabine in reducing cocaine use among methadone‐treated patients. Design Ten‐week randomized double‐blind placebo‐controlled trial. Setting Opiate Treatment Research Program, Veteran's Affairs Connecticut Healthcare System in West Haven, Connecticut, USA. Participants The participants were 45 cocaine‐dependent methadone‐treated patients who were predominately Caucasian (75.6%), male (77.8%) and never married (53%) with an average age of 38 years (SD = 6.5). Interventions Comparison groups received tiagabine 12 mg/day (n = 15), tiagabine 24 mg/day (n = 15) or placebo (n = 15). Measures Baseline assessments included the Structured Clinical Interview for DSM‐IV, the Addiction Severity Index, a urine drug test, self‐reported use and opiate withdrawal scales. Urine drug tests were performed thrice weekly. Findings Treatment retention was over 80% for all treatment groups. The sample mean (± SE) of cocaine‐free urines for the first week after study entry and before tiagabine was started was 1.16 (0.19) urines/week. During weeks 9 and 10 cocaine‐free urines increased significantly from baseline by 33% with high‐dose tiagabine (24 mg/day), by 14% with low‐dose tiagabine (12 mg/day) and decreased by 10% with placebo (hierarchical linear model, Z= 2.03; P < 0.05). Self‐reported cocaine use also decreased significantly more with active medications than with placebo. Conclusions Tiagabine at 24 mg/day was well tolerated among these methadone‐treated patients with only one reporting headache. Tiagabine appears to be a promising GABAergic medication that moderately improves cocaine‐free urines.

Journal

AddictionWiley

Published: Nov 1, 2003

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off